
Sopris Capital Associates
Description
Sopris Capital Associates is a Denver, Colorado-based private equity firm specializing in providing growth capital to promising healthcare and technology-enabled B2B service businesses. The firm distinguishes itself by partnering closely with management teams, aiming to foster the development of market-leading companies within their niche sectors. Their investment strategy is rooted in identifying businesses with strong growth potential that can benefit from strategic capital infusion and operational expertise.
The firm's investment criteria are clearly defined, targeting companies that typically generate between $5 million and $50 million in annual revenue and $1 million to $10 million in EBITDA. Sopris Capital's typical first cheque size ranges from $5 million to $20 million, reflecting their focus on growth-stage companies that have achieved a certain level of operational maturity and revenue generation. This targeted approach allows them to engage with businesses poised for significant expansion, where their capital can have a transformative impact.
Sopris Capital Associates adopts a flexible investment structure, capable of providing both minority and control capital, depending on the specific needs and objectives of the portfolio company and its management. The firm emphasizes its team's extensive operating and investment experience, leveraging this expertise to support portfolio companies through strategic guidance, operational improvements, and network access. Their commitment extends beyond mere capital provision, aiming to be a true partner in value creation for the businesses they back.
Investor Profile
Sopris Capital Associates has backed more than 49 startups, with 1 new investments in the last 12 months alone. The firm has led 29 rounds, about 59% of its total and boasts 18 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Seed rounds (top funding stages).
- Majority of deals are located in United States, Ireland, United Kingdom.
- Strong thematic focus on Health Care, Software, Medical.
- Led 1 rounds in the past year.
- Typical check size: $5M – $20M.
Stage Focus
- Series A (53%)
- Series Unknown (22%)
- Seed (8%)
- Series B (8%)
- Post Ipo Equity (4%)
- Series C (2%)
- Private Equity (2%)
Country Focus
- United States (94%)
- Ireland (2%)
- United Kingdom (2%)
- Israel (2%)
Industry Focus
- Health Care
- Software
- Medical
- Information Technology
- Analytics
- Hospital
- Brand Marketing
- Wellness
- Saas
- Fitness
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.